ISO 10993 Series Part 1: Evaluation and Testing In The Risk Management ProcessNAMSA
ISO 10993 Series Part 1: Evaluation and Testing In The Risk Management Process discusses what ISO 10993-1 addresses, as well as the general principles governing the biological evaluation of medical devices within a risk management process.
ICH Q3D - Elemental impurities in pharmaceutical productspi
The ICH has developed the Q3D guideline on elemental impurities. Both the FDA and the EMA encourage the ICH Q3D guideline implementation. All companies will have to be compliant for already authorised and marketed products as of December 2017.
Integration of Risk Assessment and Chemical Characterization (MD&M Minn. 2017)Russell Sloboda
The Toxicological Risk Assessment (TRA) is an important tool in the safety assessment of biomedical devices, providing a chemical-based approach which complements a traditional animal-based testing program. The need for TRA is growing and in some cases, may be considered as a means of circumventing animal testing in the safety evaluation of devices.
Based on results of the chemical characterization, the TRA provides context to the chemistry data and the leachable compounds identified therein, which includes compounds expected to be found and compounds that are unexpected. The objective of the chemical characterization study is to identify and quantify substances that may be released from the test article during clinical use and in practical terms, is comprised of incubations of the test article in various media, e.g., water, ethanol, or hexane, at specific temperatures and durations.
By considering the end use of the characterization data in the TRA during the design of the chemical characterization study it can be assured that the study provides the most useful and informative data. Considering the needs of the TRA can also help in determining appropriate detection limits for the analysis, which in turn can help in determining the amount of test material needed for the study. Further, coordinating with the risk assessment team during the design of characterization study helps ensure that the data are usable and presented in the most suitable manner. By working together, the TRA and chemical characterization study provide an understanding of the impact of potential exposures on the overall safety of a device.
ISO 10993 Series Part 1: Evaluation and Testing In The Risk Management ProcessNAMSA
ISO 10993 Series Part 1: Evaluation and Testing In The Risk Management Process discusses what ISO 10993-1 addresses, as well as the general principles governing the biological evaluation of medical devices within a risk management process.
ICH Q3D - Elemental impurities in pharmaceutical productspi
The ICH has developed the Q3D guideline on elemental impurities. Both the FDA and the EMA encourage the ICH Q3D guideline implementation. All companies will have to be compliant for already authorised and marketed products as of December 2017.
Integration of Risk Assessment and Chemical Characterization (MD&M Minn. 2017)Russell Sloboda
The Toxicological Risk Assessment (TRA) is an important tool in the safety assessment of biomedical devices, providing a chemical-based approach which complements a traditional animal-based testing program. The need for TRA is growing and in some cases, may be considered as a means of circumventing animal testing in the safety evaluation of devices.
Based on results of the chemical characterization, the TRA provides context to the chemistry data and the leachable compounds identified therein, which includes compounds expected to be found and compounds that are unexpected. The objective of the chemical characterization study is to identify and quantify substances that may be released from the test article during clinical use and in practical terms, is comprised of incubations of the test article in various media, e.g., water, ethanol, or hexane, at specific temperatures and durations.
By considering the end use of the characterization data in the TRA during the design of the chemical characterization study it can be assured that the study provides the most useful and informative data. Considering the needs of the TRA can also help in determining appropriate detection limits for the analysis, which in turn can help in determining the amount of test material needed for the study. Further, coordinating with the risk assessment team during the design of characterization study helps ensure that the data are usable and presented in the most suitable manner. By working together, the TRA and chemical characterization study provide an understanding of the impact of potential exposures on the overall safety of a device.
Considerations to Extractables and Leachables Testing SGS
How to organize Extractables Assessments? FDA continues to issue Warning Letters to companies that fail to properly complete Design Verification, Design Validation, and Process Validation, and recently to include failures of manufacturers in Risk Management. The evaluation of extractables and leachables has become an increasingly important aspect in the Quality by Design (QbD) initiative of the FDA in the area of drug product design, including materials used in the drug product production process and container and closure systems used for product packaging. This presentation provides general approaches and practical aspects in E&L testing.
ISO 10993 Biological Evaluation of Medical Devices UpdateNAMSA
The ISO 10993 Biological Evaluation of Medical Devices Update covers the revisions/updates that were discussed at the TC194 meeting in Mishima, Japan in April of 2014.
New guidelines relating to elemental impurities from the International Conference on Harmonization (ICH), Q3D Guideline for Elemental Impurities have presented the pharmaceutical industry with new challenges. This new guidance has been developed to provide a global policy for limiting metal impurities qualitatively and quantitatively in drug products and ingredients.
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s).
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
This presentation gives an idea about extractable and leachables, Analytical techniques used for conducting studies. importance of conducting E&L studies.
In this slide contains definition and details of Qualification Of HPLC
Presented by: KHALID KUWAITY (Department of pharmaceutical analysis).RIPER, anantapur
Understanding How Bioburden and Sterilization Affect Medical DevicesPacific BioLabs
This presentation covers:
Bioburden- what is it and how it can affect a device development program and sterilization validation program.
Sterilization: methods and the bioburden-sterilization connection.
Benefits of minimizing the sterilization dose for your device.
Importance of monitoring bioburden.
Case study: sterilization failure and tracking down root cause.
How to monitor and reduce bioburden levels.
Considerations to Extractables and Leachables Testing SGS
How to organize Extractables Assessments? FDA continues to issue Warning Letters to companies that fail to properly complete Design Verification, Design Validation, and Process Validation, and recently to include failures of manufacturers in Risk Management. The evaluation of extractables and leachables has become an increasingly important aspect in the Quality by Design (QbD) initiative of the FDA in the area of drug product design, including materials used in the drug product production process and container and closure systems used for product packaging. This presentation provides general approaches and practical aspects in E&L testing.
ISO 10993 Biological Evaluation of Medical Devices UpdateNAMSA
The ISO 10993 Biological Evaluation of Medical Devices Update covers the revisions/updates that were discussed at the TC194 meeting in Mishima, Japan in April of 2014.
New guidelines relating to elemental impurities from the International Conference on Harmonization (ICH), Q3D Guideline for Elemental Impurities have presented the pharmaceutical industry with new challenges. This new guidance has been developed to provide a global policy for limiting metal impurities qualitatively and quantitatively in drug products and ingredients.
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s).
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
This presentation gives an idea about extractable and leachables, Analytical techniques used for conducting studies. importance of conducting E&L studies.
In this slide contains definition and details of Qualification Of HPLC
Presented by: KHALID KUWAITY (Department of pharmaceutical analysis).RIPER, anantapur
Understanding How Bioburden and Sterilization Affect Medical DevicesPacific BioLabs
This presentation covers:
Bioburden- what is it and how it can affect a device development program and sterilization validation program.
Sterilization: methods and the bioburden-sterilization connection.
Benefits of minimizing the sterilization dose for your device.
Importance of monitoring bioburden.
Case study: sterilization failure and tracking down root cause.
How to monitor and reduce bioburden levels.
Use of Chemical Characterization to Assess the Equivalency of Medical Devices...NAMSA
Use of Chemical Characterization to Assess the Equivalency of Medical Devices and Materials describes chemical characterization techniques and why they are important.
Presented by Fallbrook Engineering President/CEO Richard Meyst for UCSD's Overview of FDA Regulations for Medical Device Professionals and SDSU's Current Good Manufacturing Practices: Advanced Topics.
Meta Analysis of Medical Device Data Applications for Designing Studies and R...NAMSA
Meta Analysis of Medical Device Data Applications for Designing Studies and Reinforcing Clinical Evidence discusses what meta analysis is as well as the potential benefits.
Woodbay Ltd Takes Initiative by Transitioning to ISO 9001:2015SGS
Woodbay Ltd is a care home provider for elderly residents based in Scotland.
Due to the nature of a care home’s operations it is essential that high levels of quality and safety are maintained at all times. By cultivating a culture of continuous improvement alongside ISO 9001, Woodbay is committed to ensuring that these needs are met.
Our Group Profile, including vision, mission, history, values and financial highlights. Find out more about us on our website: http://www.sgs.com/en/Our-Company/About-SGS/SGS-in-Brief.aspx
This document provides an overview of how we contribute to sustainability, demonstrated by case studies from our operations and services, and a summary of performance.
Pesticides are a vital part of the agriculture industry, assisting growers in meeting world food demands. Due to the potential negative impacts of pesticides on human and animal health as well as the environment, however, chemical pesticide residues in food or feed that is meant for human or animal consumption can be dangerous.
SGS provides a wide range of pesticide residue tests to ensure that you comply with the maximum residue levels set by many countries. Find out more: http://www.sgs.com/en/agriculture-food/food/food-contaminant-testing/pesticide-residue-testing
NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY (PHARMACY INSTITUTE) Test item characterization Presented by: Arbaz Khan M.Pharm 2nd semester Submitted to: Dr. Saumya Das Associate Professor NIET(Pharmacy Institute).
Background
Definitions
Roles and responsibilities
Transport and receipt
Identification, labelling and sampling
Characterisation
Handling and disposal
References
Established in 2012, EFRAC is a USFDA Inspected & BSE Listed Company having ISO
17025:2005 Accreditation in Chemical & Biological disciplines. Drugs & Cosmetics Division at
EFRAC is and advanced Pharmaceutical Testing Facility with Cutting-Edge Technology, 21 CFR Part
11 enabled & DQ, IQ, OQ, PQ, Qualified Instrumentation. EFRAC conducts a wide range of Tests in
Strict adherence to the Scientifically Approved Protocols and Standards by Drug Regulators like
CDSCO, WHO, MHRA & USFDA.
GLP applies to nonclinical studies conducted for the assessment of the safety or efficacy of chemicals (including pharmaceuticals).
GLP helps assure regulatory authorities that the data submitted are a true.
Is a procedure or set of procedures intended to ensure that a manufactured or performed service adheres to a defined set of quality criteria or meets the requirements of client or customer. QC is similar to, but not identical with, quality assurance (QA)
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Chemical Characterization of Medical Device Catheters
1. Chemical and Bioanalytical
Approaches for the Analysis of
Catheters and Drug Coated Balloons
Erik Foehr, Ph.D.
Vice President
Pacific BioLabs
2. Pacific BioLabs
• BioPharmaceutical and
Medical Device CRO
• Three Functional Areas
• Toxicology
• Microbiology
• Analytical
• Focus on personalized,
attentive service
• 30-year history
• GMP and GLP Compliant
Laboratories
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
3. Why chemical characterization of
medical device materials?
• Analytical chemistry studies help to evaluate
hazards that are associated with the device or
manufacturing process
• Support process control in manufacturing
• Demonstrate equivalency of proposed
materials to a clinically established material
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
4. Approach to characterization
• Review regulatory guidances for device type
• Design chemical characterization study
• Identify instrumentation and analysis
• Perform chemical classification and possible
identification
• Provide risk assessment with chemical and
biocompatibility data
• Support regulatory filing
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
5. Regulatory guidance
• ISO Guidance for Biological Evaluation of Medical
Devices
• 10993 Part 12: Sample preparation and reference
materials
• 10993 Part 18: Chemical characterization of materials
• FDA
• GLP 21 CFR Part 58
• GMP 21 CFR Part 210 & 211
• USP and ICH
• Elemental Impurities by USP <232> and <233>
• Elemental Impurities Guideline ICH Q3D
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
6. Chemical characterization
• Considerations for the analytical approach
• Intended use of device
• Contact time (blood, mucosal, skin contact)
• Material composition
• Surface area calculations
• Extractables
• Design study and choose solvents, temperature, and
duration
• Leachables
• Consider drug formulation (buffer, salts, etc)
• Storage and handling of drug and delivery device or
container
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
7. Instrumentation and analysis
• Gas Chromatography (GC) for volatile organics
• GC with Mass Spectrometry (MS) detection for
analyte identification
• High Performance Liquid Chromatography (HPLC)
• HPLC with MS detection for non-volatile /semi-volatile
analyte identification
• Inductively Coupled Plasma Mass Spectrometry
(ICP-MS) for elemental analysis -heavy metals and
other process impurities
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
8. Chemical classification and
identification
• Heavy Metals and other elements from the
needle or tubing may leach or be extracted
from the device.
• Polymers/Lubricants from the device or
manufacturing process can be monitored by
HPLC with laser light scattering or LC/MS.
• Solvents, plasticizers, and degradation
products are often identified by GC/MS.
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
9. Compound classification and risk
assessment
• Gather information about the device material,
processing, cleaning, packaging, storage
• Test material for Leachables & Extractables
• A toxicologist can help assess risk. They can
search chemical compound databases and
calculate safe exposure levels.
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
10. Case studies of catheter material
• Long History of Use
• Types of materials
• Silicones
• Polyvinyl Chloride
• Latex Rubber
• Polymeric coatings
• Chemical characterization
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
11. Catheters for chemotherapy
• Many chemotherapy agents
need to be delivered via
catheters to ensure proper
dosage and localized delivery
• The catheter may be a
temporary angiocatheter or
implanted/tunneled catheter.
• The catheter must be safe, have
minimal extractables &
leachables and effectively deliver
the chemotherapy agent.
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
12. Leachables, Extractables, and
Adsorption
• Analysis of commonly used chemotherapy agents
in catheter assemblies
• Do chemicals from the catheter assembly leach into
the formulated drug?
° Measure semi-volatile and volatile organics by GC/MS
° Measure inorganics (heavy metals) by ICP-MS
• Extract chemicals from the catheter assembly
° Place catheter into solvents such as water or ethanol at
elevated temperature (50 °C) for 24-72 hours and test for
chemical “fingerprints” with GC, GC/MS, LC/MS, or ICP-MS.
• Does the drug adhere to the catheter surface?
° Measure drug concentration before and after incubation
with catheter using HPLC or other analytical approach.
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
13. Drug coated balloon catheter
• Paclitaxel coated balloon
catheter
• Analysis of paclitaxel
concentrations in blood from
animal studies using LC/MS.
• Measurement of residual
paclitaxel from balloon surface by
HPLC.
• Analysis of matrix or coating
components
° Measure kinetics of paclitaxel release
from catheter surface
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
14. • Paclitaxel coated
balloon catheter
• Animal study of
catheter safety
and efficacy.
• Measurement of
residual paclitaxel
from balloon
surface by HPLC.
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014
Paclitaxel Concentration
Area Counts
15. Summary
• Biocompatibility and chemical
characterization of medical devices is key to
success
• Follow the guidances and use a solid scientific
rationale
• Utilize modern analytical techniques and
instrumentation
• Provide risk assessment using chemical,
biocompatibility and patient exposure data
Chemical Characterization of Catheter Devices – Pacific BioLabs, 2014